Type I Interferon Receptor Antagonists [MoA] - N0000193968
Pharmacologic Class Information
| Pharmacologic Code | N0000193968 |
| Pharmacologic Name | Type I Interferon Receptor Antagonists |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Type I Interferon Receptor Antagonists
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Type I Interferon Receptor Antagonists [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0310-3040 | Saphnelo | Non-Proprietary Name: Anifrolumab | Injection, Solution | Intravenous | Astrazeneca Pharmaceuticals Lp | ACTIVE |